Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology
- 1 September 1983
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 85 (3) , 713-717
- https://doi.org/10.1016/0016-5085(83)90030-6
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Hepatitis B core antigen in hepatocytes of patients with chronic active hepatitisDigestive Diseases and Sciences, 1980
- Evidence for hepatitis B and other virus infection in HBsAg-negative chronic active hepatitisDigestive Diseases and Sciences, 1980
- Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis.Gut, 1980
- Detection of Antibodies Directed against a Liver-Specific Membrane Lipoprotein in Patients with Acute and Chronic Active HepatitisNew England Journal of Medicine, 1978
- Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.Gut, 1976
- Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.Gut, 1975
- Paraproteins with antibody activity in acute viral hepatitis and chronic autoimmune liver diseasesGut, 1974
- CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITISThe Lancet, 1973
- Drug-induced active chronic hepatitisDigestive Diseases and Sciences, 1973
- DISTINCTIONS IN CHRONIC ACTIVE HEPATITIS BASED ON CIRCULATING HEPATITIS-ASSOCIATED ANTIGENThe Lancet, 1970